Healthpeak Properties (DOC) Stock Price, News & Analysis

Company Overview

Healthpeak Properties, Inc. is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies. These facilities are designed to meet the stringent requirements of scientific research, including wet lab space, specialized HVAC systems and flexible floor plans. The medical office segment encompasses outpatient clinics, physician practices and ancillary healthcare tenants, offering modern, patient-friendly environments in close proximity to major hospitals and healthcare systems.

Healthpeak’s senior housing division includes both skilled nursing facilities and assisted living communities, operated by third-party managers under long-term lease agreements. These properties serve a demographic seeking continuum-of-care options, combining residential living with access to medical and therapeutic services. By diversifying across these three core segments, the company aims to balance stable income streams with the potential for growth tied to advances in healthcare delivery and research.

Originally founded as Health Care REIT in 2003, the company underwent a rebranding to HCP, Inc. in 2016 and adopted the name Healthpeak Properties in 2021. Under the leadership of CEO Gregory J. Dunivan, appointed in 2019, Healthpeak continues to refine its portfolio through strategic dispositions and targeted development, focusing on markets such as Boston, San Francisco, San Diego, New York and Houston. This concentrated approach supports its goal of delivering value to stakeholders while addressing the real estate needs of the healthcare community.

Key Stats

• Today's Range: $18.07 to $18.42
• 50-Day Range: $16.75 to $19.05
• 52-Week Range: $16.63 to $23.26
• Volume: 5.90 million shs
• Average Volume: 6.20 million shs
• Market Capitalization: $12.77 billion
• P/E Ratio: 76.56
• Dividend Yield: 6.64%
• Price Target: $21.50
• Consensus Rating: Moderate Buy

Healthpeak Properties Stock Analysis - MarketRank™

Healthpeak Properties scored higher than 99% of companies evaluated by MarketBeat, and ranked 20th out of 925 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Healthpeak Properties has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Healthpeak Properties has a consensus price target of $21.50, representing about 17.0% upside from its current price of $18.37.

Amount of Analyst Coverage

Healthpeak Properties has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.84%

Earnings Growth

Earnings for Healthpeak Properties are expected to grow by 4.84% in the coming year, from $1.86 to $1.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Healthpeak Properties is 76.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 278.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of Healthpeak Properties is 76.56, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 232.42.

Price to Earnings Growth Ratio

Healthpeak Properties has a PEG Ratio of 2.32. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Healthpeak Properties has a P/B Ratio of 1.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.55% of the outstanding shares of Healthpeak Properties have been sold short.

Short Interest Ratio / Days to Cover

Healthpeak Properties has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Healthpeak Properties has recently decreased by 15.83%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Healthpeak Properties is a leading dividend payer. It pays a dividend yield of 6.88%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Healthpeak Properties does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Healthpeak Properties is 508.33%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Healthpeak Properties will have a dividend payout ratio of 62.56% next year. This indicates that Healthpeak Properties will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.7 / 5
• Environmental Score: -3.24

Percentage of Shares Shorted

2.55% of the outstanding shares of Healthpeak Properties have been sold short.

Short Interest Ratio / Days to Cover

Healthpeak Properties has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Healthpeak Properties has recently decreased by 15.83%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.42

News Sentiment

Healthpeak Properties has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Healthpeak Properties this week, compared to 16 articles on an average week.

Search Interest

Only 40 people have searched for DOC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

29 people have added Healthpeak Properties to their MarketBeat watchlist in the last 30 days. This is an increase of 480% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Healthpeak Properties insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,129.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.23% of the stock of Healthpeak Properties is held by insiders.

Percentage Held by Institutions

93.57% of the stock of Healthpeak Properties is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DOC Stock Analysis - Frequently Asked Questions

How have DOC shares performed this year?

Healthpeak Properties' stock was trading at $20.27 at the start of the year. Since then, DOC shares have decreased by 9.4% and is now trading at $18.3740.

How were Healthpeak Properties' earnings last quarter?

Healthpeak Properties, Inc. (NYSE:DOC) announced its quarterly earnings data on Thursday, July, 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. The business's revenue was down .2% on a year-over-year basis.
Read the conference call transcript.

Who are Healthpeak Properties' major shareholders?

Top institutional investors of Healthpeak Properties include Vanguard Group Inc. (16.04%), State Street Corp (6.99%), Invesco Ltd. (3.07%) and JPMorgan Chase & Co. (2.88%). Insiders that own company stock include John T Thomas, Scott M Brinker, Tommy G Thompson, Albert Black Jr and Laurie P Becker.
View institutional ownership trends.

How do I buy shares of Healthpeak Properties?

Shares of DOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Healthpeak Properties own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Healthpeak Properties investors own include Pfizer (PFE), Realty Income (O), Medical Properties Trust (MPW), Enterprise Products Partners (EPD), Energy Transfer (ET), Boeing (BA) and Cleveland-Cliffs (CLF).

Company Calendar

• Last Earnings: 7/24/2025
• Record date for 8/29 Dividend: 8/18/2025
• Ex-Dividend for 8/29 Dividend: 8/18/2025
• Dividend Payable: 8/29/2025
• Today: 9/06/2025
• Record date for 9/30 Dividend: 9/19/2025
• Ex-Dividend for 9/30 Dividend: 9/19/2025
• Dividend Payable: 9/30/2025
• Next Earnings (Estimated): 10/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Trading
• Current Symbol: NYSE:DOC
• CIK: 765880
• Web: www.docreit.com
• Phone: (414) 367-5600
• Fax: 949-407-0800
• Employees: 200
• Year Founded: 2013

Price Target and Rating

• Average Price Target for Healthpeak Properties: $21.50
• High Price Target: $26.00
• Low Price Target: $18.00
• Potential Upside/Downside: +17.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.70
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.24
• Trailing P/E Ratio: 76.56
• Forward P/E Ratio: 9.88
• P/E Growth: 2.37
• Net Income: $243.14 million
• Net Margins: 5.90%
• Pretax Margin: 6.77%
• Return on Equity: 1.85%
• Return on Assets: 0.83%

Debt

• Debt-to-Equity Ratio: 1.06
• Current Ratio: 1.28
• Quick Ratio: 1.28

Sales & Book Value

• Annual Sales: $2.70 billion
• Price / Sales: 4.73
• Cash Flow: $1.73 per share
• Price / Cash Flow: 10.63
• Book Value: $12.95 per share
• Price / Book: 1.42

Miscellaneous

• Outstanding Shares: 694,920,000
• Free Float: 693,325,000
• Market Cap: $12.77 billion
• Optionable: Optionable
• Beta: 1.07